Infection, neutrophils, and hematopoietic growth factors in the pathogenesis of neonatal chronic lung disease

Clinics in Perinatology

Volumn 27, Issue 3, 2000, Pages 717-731

  Papoff, Paola ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CD11 ANTIGEN; CD18 ANTIGEN; CELL ADHESION MOLECULE; COLLAGEN; COLLAGENASE; COMPLEMENT; CYTOKINE; ELASTASE; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; FIBRIN DEGRADATION PRODUCT; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEMOPOIETIC GROWTH FACTOR; HYDROLASE; INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN 8; LEUKOTRIENE B4; LIPID; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; OXIDIZING AGENT; OXYGEN; PROTEINASE; PROTEINASE INHIBITOR; REACTIVE OXYGEN METABOLITE; SURFACTANT; THROMBOCYTE ACTIVATING FACTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR; UNINDEXED DRUG;

CELL MIGRATION; CHRONIC LUNG DISEASE; HUMAN; INFECTION; INFLAMMATION; LEUKOCYTE ACTIVATION; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0033836846     PISSN: 00955108     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0095-5108(05)70047-6     Document Type: Article

References (101)

1. Human granulocyte colony-stimulating factor: Its basic aspects and clinical applications
2. Granulocyte-colony stimulating factor levels in bronchoalveolar lavage fluid from patients with idiopathic pulmonary fibrosis
3. Damage to surfactant-specific protein in acute respiratory distress syndrome
4. Secretion of cytokines by rat alveolar epithelial cells: Possible regulatory role for SP-A
5. Altered urinary excretion of elastin cross-links in premature infants who develop bronchopulmonary dysplasia
6. Activation of circulating polymorphonuclear leukocytes in preterm infants with severe idiopathic respiratory distress syndrome
7. Number and activation of circulating polymorphonuclear leukocytes and platelets are associated with neonatal respiratory distress syndrome severity
8. Granulocyte-macrophage colony-stimulating factor in amniotic fluid and in airway specimens of newborn infants
9. Purification and properties of colony-stimulating factor from mouselung-conditioned medium
10. Abnormal FcRIII expression by neutrophils from very preterm neonates
11. The production of cytokines by polymorphonuclear neutrophils
12. Ureaplasma urealyticum intrauterine infection: Role in prematurity and disease in newborns
13. Neutrophils in normal lung
14. Neonatal airway colonization with gram-negative bacilli: Association with severity of bronchopulmonary dysplasia
15. The distribution of granulocyte-macrophage colony-stimulating factor and its receptor in the developing human fetus
16. Role of Ureaplasma urealyticum and Chlamydia trachomatis in development of bronchopulmonary dysplasia in very low birth weight infants
17. The regulation of phospholipase-A2 (PLA-2) by cytokines expressing hematopoietic growth-stimulating properties
18. Granulocyte colony-stimulating factor and its receptor
19. The role of neutrophil elastase in chronic inflammation
20. Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis
21. Complement anaphylatoxin C3a and C5a formation in premature children with respiratory distress
22. Cellular and molecular responses to lung injury in relation to induction of tissue repair and fibrosis
23. Increased leukocyte elastase of the tracheal aspirate at birth and neonatal pulmonary emphysema
24. Cytokines and pulmonary fibrosis
25. Exposure of the hydrophobic components of porcine lung surfactant to oxidant stress alters surface tension properties
26. Premature labor and intra-amniotic infection. Clinical aspects and role of the cytokines in diagnosis and pathophysiology
27. Influence of infection on patent ductus arteriosus and chronic lung disease in premature infants weighing 1000 grams or less
28. Increased levels of bronchoalveolar lavage fluid interleukin-6 in preterm ventilated infants after prolonged rupture of membranes
29. Neutrophil apoptosis and clearance from neonatal lungs
30. Association of pulmonary inflammation and increased microvascular permeability during the development of broncho-pulmonary dysplasia: A sequential analysis of inflammatory mediators in respiratory fluids of high-risk preterm neonates
31. Inflammatory bronchopulmonary response of preterm infants with microbial colonisation of the airways at birth
32. Levels of complement anaphylatoxin C5a in pulmonary effluent fluid of infants at risk for chronic lung disease and effects of dexamethasone treatment
33. Pulmonary inflammation in the pathogenesis of bronchopulmonary dysplasia
34. G-CSF instillation into rat lungs mediates neutrophil recruitment, pulmonary edema and hypoxia
35. Hemorrhagic shock induces G-CSF expression in bronchial epithelium
36. Proteases
37. Antiproteases
38. GM-CSF enhances lung growth and causes alveolar type epithelial cell hyperplasia in transgenic mice
39. Surfactant metabolic consequences of overexpression of GM-CSF in the epithelium of GM-CSF-deficient mice
40. Granulocyte colony-stimulating factor induces neutrophil sequestration in rabbit lungs
41. Neutrophil chemoattractants generated in two phases during reperfusion of ischemic myocardium in the rabbit. Evidence for a role for C5a and interleukin-8
42. Undetectable interleukin (IL)-10 and persistent IL-8 expression early in hyaline membrane disease: A possible developmental basis for the predisposition to chronic lung inflammation in preterm newborns
43. Early increase of TNF alpha and IL-6 in tracheobronchial aspirate fluid indicator of subsequent chronic lung disease in preterm infants
44. Mechanisms of surfactant dysfunction in early acute lung injury
45. Effect of granulocyte colony-stimulating factor on acute lung injury in the rat
46. Effect of amnionitis on the complement system of preterm infants
47. Soluble L-selectin concentration in bronchoalveolar lavage fluid obtained from infants who develop chronic lung disease of prematurity
48. Increase in the concentration of transforming growth factor beta-1 in bronchoalveolar lavage fluid before development of chronic lung disease of prematurity
49. Increase in interleukin (IL)-1 beta and IL-6 in bronchoalveolar lavage fluid obtained from infants with chronic lung disease of prematurity
50. Alveolar type II-like cells release G-CSF as neutrophil chemotactic activity
51. Human lung fibroblasts release chemokinetic activity for monocytes constitutively
52. Induction of neutrophil chemoattractant cytokines by Mycoplasma hominis in alveolar type II cells
53. Effects of a corticosteroid, budesonide, on alveolar macrophage and blood monocyte secretion of cytokines: Differential sensitivity of GM-CSF, IL-1 beta, and and IL-6
54. Role of elevated plasma soluble ICAM-1 and bronchial lavage fluid IL-8 levels as markers of chronic lung disease in premature infants
55. Consequences of proteolytic injury
56. Neutrophil apoptosis in the acute respiratory distress syndrome
57. Induction by chemokines of lipid mediator synthesis in granulocyte-macrophage colony-stimulating factor-treated human neutrophils
58. Elastase and alpha 1-proteinase inhibitor activity in tracheal aspirates during respiratory distress syndrome. Role of inflammation in the pathogenesis of bronchopulmonary dysplasia
59. Human surfactant treatment of severe respiratory distress syndrome: Pulmonary effluent indicators of lung inflammation
60. Localization of a low-molecular-weight bronchial protease inhibitor in the peripheral human lung
61. Elevation of interleukin-8 and interleukin-6 precedes the influx of neutrophils in tracheal aspirates from preterm infants who develop bronchopulmonary dysplasia
62. Early production of macrophage inflammatory protein-1 alpha occurs in respiratory distress syndrome and is associated with poor outcome
63. Mucosal tumor necrosis factor-alpha production and extensive disruption of sulfated glycosaminoglycans begin within hours of birth in neonatal respiratory distress syndrome
64. Granulocyte-macrophage colony-stimulating factor promotes the proliferation of human alveolar macrophages in vitro
65. Neonatal lung neutrophils and elastase/ proteinase inhibitor imbalance
66. Oxidation products of uric acid and ascorbic acid in preterm infants with chronic lung disease
67. Contribution of granulocyte macrophage (GM) colony stimulating factor (CSF) to airway inflammation in infants who develop chronic lung disease (CLD)
68. Increased concentrations of eosinophils in the bronchoalveolar lavage fluid of preterm infants delivered following chorioamnionitis
69. Etiology of bronchopulmonary dysplasia
70. Injury from inflammatory cells
71. Ureaplasma urealyticum respiratory tract colonization is associated with an increase in interleukin 1-beta and tumor necrosis factor alpha relative to interleukin 6 in tracheal aspirates of preterm infants
72. New prospective studies of the association of Ureaplasma urealyticum colonization and chronic lung disease
73. G-CSF increases secretion of urokinase-type plasminogen activator by human lung cancer cells
74. Effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on the bactericidal functions of neutrophils
75. Biological markers of acute lung injury: Prognostic and pathogenetic significance
76. Eosinophil cationic protein in tracheal aspirates of preterm infants with bronchopulmonary dysplasia
77. Aerosolized GM-CSF ameliorates pulmonary alveolar proteinosis in GM-CSF-deficient mice
78. Granulocyte-macrophage colony-stimulating factor and pulmonary surfactant homeostasis
79. Changing trends in the epidemiology and pathogenesis of neonatal chronic lung disease
80. Mechanisms of tissue injury by oxygen radicals: Implications for neonatal disease
81. Calcium-dependent degradation of surfactant protein A by activated neutrophils due to serine proteases
82. Inflammatory mechanisms in neonatal chronic lung disease
83. Induction of human neonatal pulmonary fibroblast cytokines by hyperoxia and Ureaplasma urealyticum
84. Potential role of eicosanoids and PAF in the pathophysiology of bronchopulmonary dysplasia
85. Acute lung injury: The role of cytokines in the elicitation of neutrophils
86. Spontaneous release of granulocyte colony-stimulating factor (G-CSF) by alveolar macrophages in the course of bacterial pneumonia and sarcoidosis: Endotoxin-dependent and endotoxin-independent G-CSF release by cells recovered by bronchoalveolar lavage
87. Elastase alpha 1-proteinase inhibitor and lactoferrin concentrations in endotracheal aspirates of ventilated newborns
88. Granulocyte-macrophage colony-stimulating factor increases surfactant phospholipid in premature rabbits
89. Alterations of ambient oxygen tension modulate the expression of tumor necrosis factor and macrophage inflammatory protein-1 alpha from murine alveolar macrophages
90. Early protein oxidation in the neonatal lung is related to development of chronic lung disease
91. Disordered pathways of fibrin turnover in lung lavage of premature infants with respiratory distress syndrome
92. Stretch induces cytokine release by alveolar epithelial cells in vitro
93. Complement and contact activation related to surfactant response in respiratory distress syndrome
94. Activated T cells and cytokines in bronchoalveolar lavages from patients with various lung diseases associated with eosinophilia
95. Persistent elastase/proteinase inhibitor imbalance during prolonged ventilation of infants with bronchopulmonary dysplasia: Evidence for the role of nosocomial infections
96. Association of Ureaplasma urealyticum colonization with chronic lung disease of prematurity: Results of a metaanalysis
97. Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops
98. Transfer of granulocyte-macrophage colony-stimulating factor gene to rat lung induces eosinophilia, monocytosis and fibrotic reactions
99. Overexpression of granulocyte-macrophage colony-stimulating factor induces pulmonary granulation tissue formation and fibrosis by induction of transforming growth factor-beta 1 and myofibroblast accumulation
100. Granulocyte-macrophage colony-stimulating factor induces neutrophil adhesion to pulmonary vascular endothelium in vivo: Role of beta 2 integrins
101. A systemic fetal inflammatory response and the development of bronchopulmonary dysplasia